Jones Soda director gets 121,213 shares via RSUs

Q: What transaction did JSDA director Clive M. Sirkin report on July 31, 2026?

He reported the vesting and settlement of 121,213 restricted stock units into the same number of Jones Soda common shares on July 31, 2026. The RSUs required no cash payment and were part of an equity grant awarded earlier in July 2026.

Q: What RSU grant did Clive M. Sirkin receive from Jones Soda (JSDA) in July 2026?

On July 15, 2026, Clive M. Sirkin was granted 242,425 restricted stock units. According to the vesting schedule, 50% vested into shares on July 31, 2026, with 25% scheduled to vest on September 30, 2026 and the remaining 25% on December 31, 2026.

Q: How many Jones Soda (JSDA) RSUs remain unvested for Clive M. Sirkin after this transaction?

After the July 31, 2026 vesting, Sirkin has 121,212 restricted stock units remaining. These unvested RSUs are scheduled to convert into Jones Soda common stock in two additional tranches later in 2026, consistent with the disclosed vesting schedule.

Q: Was this Jones Soda (JSDA) Form 4 transaction made under a Rule 10b5-1 trading plan?

The Rule 10b5-1 checkbox was not marked as affirming a trading plan, and the footnotes do not reference any 10b5-1 arrangement. The reported activity reflects scheduled RSU vesting and settlement rather than sales executed under a pre-arranged trading plan.

JONES SODA CO. director Clive M. Sirkin reported RSU vesting into common stock.

Accepted by SEC EDGAR 08/04/2026 - 06:29 PM EDT

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

JONES SODA CO. director Clive M. Sirkin reported RSU vesting into common stock. On July 31, 2026, 121,213 restricted stock units converted on a one-for-one basis into the same number of common shares without any cash payment. He now directly holds 3,162,821 common shares and 121,212 unvested RSUs, with remaining units scheduled to vest on September 30 and December 31, 2026.

Insider Trade Summary

121,213 shares exercised/converted

Exercise 2 txns

Insider SIRKIN CLIVE M

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units ^{F2, F3}	121,213	$0.00	$0.00
Exercise	Common Stock ^F1	121,213	--	--

Holdings After Transaction: Restricted Stock Units — 121,212 units (Direct); Common Stock — 3,162,821 shares (Direct)

Footnotes (3)

F1. Restricted stock units ("RSUs") converted into shares of the issuer's common stock on a one-for-one basis on the vesting date. RSUs do not require the holder to pay any consideration on vesting.
F2. Each RSU represents a contingent right to receive one (1) share of the issuer's common stock upon settlement.
F3. On July 15, 2026, the reporting person was granted 242,425 RSUs, of which 50% vested into shares on July 31, 2026, an additional 25% are scheduled to vest into shares on September 30, 2026, and the remaining 25% are scheduled to vest into shares on December 31, 2026. Upon vesting, the reporting person will receive a number of shares of the issuer's common stock equal to the number of RSUs that vest on that date.

Key Figures

RSUs converted: 121213.0000 shares Common shares held after transaction: 3162821.0000 shares RSU grant size: 242425 RSUs +1 more

4 metrics

RSUs converted 121213.0000 shares Restricted stock units converted into common stock on July 31, 2026

Common shares held after transaction 3162821.0000 shares Direct common stock holdings following July 31, 2026 RSU vesting

RSU grant size 242425 RSUs Restricted stock units granted on July 15, 2026 to Clive M. Sirkin

Unvested RSUs remaining 121212.0000 RSUs RSUs outstanding after the July 31, 2026 vesting event

Key Terms

Restricted Stock Units, contingent right, vesting date

3 terms

Restricted Stock Units financial

"Security title listed as "Restricted Stock Units" for the derivative entry"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

contingent right financial

"Each RSU represents a contingent right to receive one (1) share"

vesting date financial

"RSUs converted into shares of the issuer's common stock on the vesting date"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What transaction did JSDA director Clive M. Sirkin report on July 31, 2026?

He reported the vesting and settlement of 121,213 restricted stock units into the same number of Jones Soda common shares on July 31, 2026. The RSUs required no cash payment and were part of an equity grant awarded earlier in July 2026.

How many Jones Soda (JSDA) common shares does Clive M. Sirkin hold after this Form 4?

Following the reported RSU conversion, Clive M. Sirkin directly holds 3,162,821 Jones Soda common shares. In addition, he holds 121,212 unvested restricted stock units that are scheduled to convert into additional shares as they vest later in 2026.

What RSU grant did Clive M. Sirkin receive from Jones Soda (JSDA) in July 2026?

On July 15, 2026, Clive M. Sirkin was granted 242,425 restricted stock units. According to the vesting schedule, 50% vested into shares on July 31, 2026, with 25% scheduled to vest on September 30, 2026 and the remaining 25% on December 31, 2026.

How many Jones Soda (JSDA) RSUs remain unvested for Clive M. Sirkin after this transaction?

After the July 31, 2026 vesting, Sirkin has 121,212 restricted stock units remaining. These unvested RSUs are scheduled to convert into Jones Soda common stock in two additional tranches later in 2026, consistent with the disclosed vesting schedule.

Was this Jones Soda (JSDA) Form 4 transaction made under a Rule 10b5-1 trading plan?

The Rule 10b5-1 checkbox was not marked as affirming a trading plan, and the footnotes do not reference any 10b5-1 arrangement. The reported activity reflects scheduled RSU vesting and settlement rather than sales executed under a pre-arranged trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SIRKIN CLIVE M

(Last)

(First)

(Middle)

1522 WESTERN AVE.,

SUITE 24150

(Street)

SEATTLE

WASHINGTON

98101

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
JONES SODA CO. [ JSDA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	07/31/2026		M		121,213	A	⁽¹⁾	3,162,821	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	⁽²⁾	07/31/2026		M			121,213	⁽³⁾	⁽³⁾	Common Stock	121,213	$0	121,212	D

Explanation of Responses:

1. Restricted stock units ("RSUs") converted into shares of the issuer's common stock on a one-for-one basis on the vesting date. RSUs do not require the holder to pay any consideration on vesting.

2. Each RSU represents a contingent right to receive one (1) share of the issuer's common stock upon settlement.

3. On July 15, 2026, the reporting person was granted 242,425 RSUs, of which 50% vested into shares on July 31, 2026, an additional 25% are scheduled to vest into shares on September 30, 2026, and the remaining 25% are scheduled to vest into shares on December 31, 2026. Upon vesting, the reporting person will receive a number of shares of the issuer's common stock equal to the number of RSUs that vest on that date.

	/s/ Brian Meadows, Attorney-in-Fact for Clive Sirkin	08/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR